In contrast, miR-192 suppressed cell adhesion by binding ITGAV and ITGB3. ITGB3 is mostly associated with the ability of tumor metastases to promote extravasation from the primary tumor, cell adhesion, intravasation, and tumor growth at the metastatic site [23, 24]. Here, ITGAV is linked to neoplasm.